FDA warns Costa Ricas Polimeros y Servicios about CGMP and other violations in its manufacturing of OTC drugs.
FDA releases its latest batch of Warning Letters that includes Balamurali K. Ambati, Haw Par Healthcare, Metuchen Pharmaceuticals, Polimeros y Servici...
An annual Gallup Work and Education poll shows the pharmaceutical industry is the most poorly regarded industry by Americans, falling below even the f...
FDA says a Tennessee federal judge entered a consent decree against two companies to prohibit them from distributing drugs, dietary supplements, or me...
FDA Review has posted the Federal Register notices for the week ending 8/30/2019.
FDA Review posts product approval summaries for the week ending 8/30/2019.
Novartis says it will file a BLA and seek other global approvals for its leukemia drug Arzerra (ofatumumab) and its use in treating relapsing forms of...